ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha Blockers Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-23K6808
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Alpha Blockers Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alpha Blockers Market Research Report 2025

Code: QYRE-Auto-23K6808
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Alpha Blockers Market

The global market for Alpha Blockers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Alpha-blockers, also known as α-blockers or α-adrenoreceptor antagonists, are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
North American market for Alpha Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alpha Blockers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Alpha Blockers include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Blockers.
The Alpha Blockers market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha Blockers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha Blockers Market Report

Report Metric Details
Report Name Alpha Blockers Market
Segment by Type
  • Non-selective Antagonists
  • Selective Antagonists
Segment by Application
  • Hypertension
  • Raynaud's Disease
  • Erectile Dysfunction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alpha Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alpha Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Alpha Blockers Market report?

Ans: The main players in the Alpha Blockers Market are Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical

What are the Application segmentation covered in the Alpha Blockers Market report?

Ans: The Applications covered in the Alpha Blockers Market report are Hypertension, Raynaud's Disease, Erectile Dysfunction

What are the Type segmentation covered in the Alpha Blockers Market report?

Ans: The Types covered in the Alpha Blockers Market report are Non-selective Antagonists, Selective Antagonists

1 Alpha Blockers Market Overview
1.1 Product Definition
1.2 Alpha Blockers by Type
1.2.1 Global Alpha Blockers Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-selective Antagonists
1.2.3 Selective Antagonists
1.3 Alpha Blockers by Application
1.3.1 Global Alpha Blockers Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Raynaud's Disease
1.3.4 Erectile Dysfunction
1.4 Global Alpha Blockers Market Size Estimates and Forecasts
1.4.1 Global Alpha Blockers Revenue 2020-2031
1.4.2 Global Alpha Blockers Sales 2020-2031
1.4.3 Global Alpha Blockers Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alpha Blockers Market Competition by Manufacturers
2.1 Global Alpha Blockers Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alpha Blockers Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alpha Blockers Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alpha Blockers, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alpha Blockers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha Blockers, Product Type & Application
2.7 Global Key Manufacturers of Alpha Blockers, Date of Enter into This Industry
2.8 Global Alpha Blockers Market Competitive Situation and Trends
2.8.1 Global Alpha Blockers Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alpha Blockers Players Market Share by Revenue
2.8.3 Global Alpha Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alpha Blockers Market Scenario by Region
3.1 Global Alpha Blockers Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alpha Blockers Sales by Region: 2020-2031
3.2.1 Global Alpha Blockers Sales by Region: 2020-2025
3.2.2 Global Alpha Blockers Sales by Region: 2026-2031
3.3 Global Alpha Blockers Revenue by Region: 2020-2031
3.3.1 Global Alpha Blockers Revenue by Region: 2020-2025
3.3.2 Global Alpha Blockers Revenue by Region: 2026-2031
3.4 North America Alpha Blockers Market Facts & Figures by Country
3.4.1 North America Alpha Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alpha Blockers Sales by Country (2020-2031)
3.4.3 North America Alpha Blockers Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alpha Blockers Market Facts & Figures by Country
3.5.1 Europe Alpha Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alpha Blockers Sales by Country (2020-2031)
3.5.3 Europe Alpha Blockers Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha Blockers Market Facts & Figures by Region
3.6.1 Asia Pacific Alpha Blockers Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alpha Blockers Sales by Region (2020-2031)
3.6.3 Asia Pacific Alpha Blockers Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alpha Blockers Market Facts & Figures by Country
3.7.1 Latin America Alpha Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alpha Blockers Sales by Country (2020-2031)
3.7.3 Latin America Alpha Blockers Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha Blockers Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha Blockers Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alpha Blockers Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alpha Blockers Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Alpha Blockers Sales by Type (2020-2031)
4.1.1 Global Alpha Blockers Sales by Type (2020-2025)
4.1.2 Global Alpha Blockers Sales by Type (2026-2031)
4.1.3 Global Alpha Blockers Sales Market Share by Type (2020-2031)
4.2 Global Alpha Blockers Revenue by Type (2020-2031)
4.2.1 Global Alpha Blockers Revenue by Type (2020-2025)
4.2.2 Global Alpha Blockers Revenue by Type (2026-2031)
4.2.3 Global Alpha Blockers Revenue Market Share by Type (2020-2031)
4.3 Global Alpha Blockers Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alpha Blockers Sales by Application (2020-2031)
5.1.1 Global Alpha Blockers Sales by Application (2020-2025)
5.1.2 Global Alpha Blockers Sales by Application (2026-2031)
5.1.3 Global Alpha Blockers Sales Market Share by Application (2020-2031)
5.2 Global Alpha Blockers Revenue by Application (2020-2031)
5.2.1 Global Alpha Blockers Revenue by Application (2020-2025)
5.2.2 Global Alpha Blockers Revenue by Application (2026-2031)
5.2.3 Global Alpha Blockers Revenue Market Share by Application (2020-2031)
5.3 Global Alpha Blockers Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Alpha Blockers Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Alpha Blockers Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Alpha Blockers Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Company Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astra Zeneca Alpha Blockers Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Company Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jhonson and Johnson Alpha Blockers Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Alpha Blockers Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Alpha Blockers Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Alpha Blockers Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Alpha Blockers Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Alpha Blockers Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Company Information
6.11.2 Teva Pharmaceutical Description and Business Overview
6.11.3 Teva Pharmaceutical Alpha Blockers Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceutical Alpha Blockers Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha Blockers Industry Chain Analysis
7.2 Alpha Blockers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha Blockers Production Mode & Process Analysis
7.4 Alpha Blockers Sales and Marketing
7.4.1 Alpha Blockers Sales Channels
7.4.2 Alpha Blockers Distributors
7.5 Alpha Blockers Customer Analysis
8 Alpha Blockers Market Dynamics
8.1 Alpha Blockers Industry Trends
8.2 Alpha Blockers Market Drivers
8.3 Alpha Blockers Market Challenges
8.4 Alpha Blockers Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical
List of Tables
 Table 1. Global Alpha Blockers Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alpha Blockers Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alpha Blockers Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alpha Blockers Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Alpha Blockers Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alpha Blockers Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alpha Blockers Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alpha Blockers Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alpha Blockers, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alpha Blockers, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alpha Blockers, Product Type & Application
 Table 12. Global Key Manufacturers of Alpha Blockers, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alpha Blockers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Blockers as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alpha Blockers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alpha Blockers Sales by Region (2020-2025) & (K MT)
 Table 18. Global Alpha Blockers Sales Market Share by Region (2020-2025)
 Table 19. Global Alpha Blockers Sales by Region (2026-2031) & (K MT)
 Table 20. Global Alpha Blockers Sales Market Share by Region (2026-2031)
 Table 21. Global Alpha Blockers Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alpha Blockers Revenue Market Share by Region (2020-2025)
 Table 23. Global Alpha Blockers Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alpha Blockers Revenue Market Share by Region (2026-2031)
 Table 25. North America Alpha Blockers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alpha Blockers Sales by Country (2020-2025) & (K MT)
 Table 27. North America Alpha Blockers Sales by Country (2026-2031) & (K MT)
 Table 28. North America Alpha Blockers Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alpha Blockers Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alpha Blockers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alpha Blockers Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Alpha Blockers Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Alpha Blockers Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alpha Blockers Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alpha Blockers Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alpha Blockers Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Alpha Blockers Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Alpha Blockers Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alpha Blockers Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alpha Blockers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alpha Blockers Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Alpha Blockers Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Alpha Blockers Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha Blockers Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alpha Blockers Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alpha Blockers Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Alpha Blockers Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Alpha Blockers Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alpha Blockers Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alpha Blockers Sales (K MT) by Type (2020-2025)
 Table 51. Global Alpha Blockers Sales (K MT) by Type (2026-2031)
 Table 52. Global Alpha Blockers Sales Market Share by Type (2020-2025)
 Table 53. Global Alpha Blockers Sales Market Share by Type (2026-2031)
 Table 54. Global Alpha Blockers Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alpha Blockers Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alpha Blockers Revenue Market Share by Type (2020-2025)
 Table 57. Global Alpha Blockers Revenue Market Share by Type (2026-2031)
 Table 58. Global Alpha Blockers Price (USD/MT) by Type (2020-2025)
 Table 59. Global Alpha Blockers Price (USD/MT) by Type (2026-2031)
 Table 60. Global Alpha Blockers Sales (K MT) by Application (2020-2025)
 Table 61. Global Alpha Blockers Sales (K MT) by Application (2026-2031)
 Table 62. Global Alpha Blockers Sales Market Share by Application (2020-2025)
 Table 63. Global Alpha Blockers Sales Market Share by Application (2026-2031)
 Table 64. Global Alpha Blockers Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alpha Blockers Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alpha Blockers Revenue Market Share by Application (2020-2025)
 Table 67. Global Alpha Blockers Revenue Market Share by Application (2026-2031)
 Table 68. Global Alpha Blockers Price (USD/MT) by Application (2020-2025)
 Table 69. Global Alpha Blockers Price (USD/MT) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Pfizer Alpha Blockers Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Novartis Alpha Blockers Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck Alpha Blockers Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Astra Zeneca Company Information
 Table 86. Astra Zeneca Description and Business Overview
 Table 87. Astra Zeneca Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Astra Zeneca Alpha Blockers Product
 Table 89. Astra Zeneca Recent Developments/Updates
 Table 90. Jhonson and Johnson Company Information
 Table 91. Jhonson and Johnson Description and Business Overview
 Table 92. Jhonson and Johnson Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Jhonson and Johnson Alpha Blockers Product
 Table 94. Jhonson and Johnson Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Eli Lilly Alpha Blockers Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Sanofi Alpha Blockers Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Alpha Blockers Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bayer Alpha Blockers Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. GSK Alpha Blockers Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Teva Pharmaceutical Company Information
 Table 121. Teva Pharmaceutical Description and Business Overview
 Table 122. Teva Pharmaceutical Alpha Blockers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceutical Alpha Blockers Product
 Table 124. Teva Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Alpha Blockers Distributors List
 Table 128. Alpha Blockers Customers List
 Table 129. Alpha Blockers Market Trends
 Table 130. Alpha Blockers Market Drivers
 Table 131. Alpha Blockers Market Challenges
 Table 132. Alpha Blockers Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alpha Blockers
 Figure 2. Global Alpha Blockers Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha Blockers Market Share by Type: 2024 & 2031
 Figure 4. Non-selective Antagonists Product Picture
 Figure 5. Selective Antagonists Product Picture
 Figure 6. Global Alpha Blockers Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Alpha Blockers Market Share by Application: 2024 & 2031
 Figure 8. Hypertension
 Figure 9. Raynaud's Disease
 Figure 10. Erectile Dysfunction
 Figure 11. Global Alpha Blockers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Alpha Blockers Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Alpha Blockers Sales (2020-2031) & (K MT)
 Figure 14. Global Alpha Blockers Average Price (USD/MT) & (2020-2031)
 Figure 15. Alpha Blockers Report Years Considered
 Figure 16. Alpha Blockers Sales Share by Manufacturers in 2024
 Figure 17. Global Alpha Blockers Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Alpha Blockers Players: Market Share by Revenue in Alpha Blockers in 2024
 Figure 19. Alpha Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Alpha Blockers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Alpha Blockers Sales Market Share by Country (2020-2031)
 Figure 22. North America Alpha Blockers Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Alpha Blockers Sales Market Share by Country (2020-2031)
 Figure 26. Europe Alpha Blockers Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Alpha Blockers Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Alpha Blockers Revenue Market Share by Region (2020-2031)
 Figure 34. China Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Alpha Blockers Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Alpha Blockers Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Alpha Blockers Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Alpha Blockers Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Alpha Blockers Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Alpha Blockers by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Alpha Blockers by Type (2020-2031)
 Figure 56. Global Alpha Blockers Price (USD/MT) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Alpha Blockers by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Alpha Blockers by Application (2020-2031)
 Figure 59. Global Alpha Blockers Price (USD/MT) by Application (2020-2031)
 Figure 60. Alpha Blockers Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global α blocker Market Research Report 2024
Global α adrenoreceptor Antagonists Market Research Report 2024
Global Beta Blockers Market Research Report 2025
Global β blockers Market Research Report 2024
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global α Adrenergic Agonist Market Research Report 2024
Adrenoceptor Blocking Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Doxazosin Mesylate Market Research Report 2024
Global Antihypertensive Drugs Market Research Report 2024
Global Alfuzosin Market Insights Forecast to 2030
Nifedipine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 5 Hydroxytryptamine Receptor Blocker Market Research Report 2025
Global Calcium Channel Antagonist Market Research Report 2024
H2 Antagonists or H2 blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Adrenergic Agent Market Research Report 2024
Global Benign Prostate Hyperplasia Drugs Market Insights Forecast to 2030
Global Carvedilol Tablets Market Research Report 2024
Global Estrogen Blocker Market Research Report 2025
Histamine H2 receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alpha receptor Antagonists Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions